Frontage Holdings Completes Major Connected Acquisition and Consolidates New Subsidiary

Frontage Holdings Corp. ( (HK:1521) ) has shared an update.

Frontage Holdings Corporation has completed its previously announced acquisition of the entire issued share capital of a target company, following shareholder approval at an extraordinary general meeting. The deal, classified as a major and connected transaction, makes the target a wholly owned subsidiary and will see its financial results consolidated into Frontage’s group accounts, potentially expanding the group’s operational scale and financial footprint in its core service areas.

The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.

More about Frontage Holdings Corp.

Frontage Holdings Corporation is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. It operates in the life sciences and pharmaceutical services sector, providing research and development support as part of a broader contract research and related services platform to global biopharmaceutical clients.

Average Trading Volume: 167,289

Technical Sentiment Signal: Sell

Current Market Cap: HK$2.2B

Learn more about 1521 stock on TipRanks’ Stock Analysis page.